Related Experiment Video
Updated: Dec 23, 2025

06:51
A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
5.7K
Propranolol-resistant infantile hemangioma successfully treated with sirolimus
Victoria L Dávila-Osorio1, Helena Iznardo1, Esther Roé1
1Department of Dermatology, Hospital Sant Joan de Deu, Barcelona, Spain.
Pediatric Dermatology
|April 24, 2020
Abstract:
Infantile hemangiomas are the most common benign vascular tumors in childhood. Propranolol is the first-line treatment for infantile hemangiomas, but failures may occur. Sirolimus, an mTOR inhibitor, is a promising drug for the treatment of vascular malformations and vascular tumors. We present the case of a child with multiple infantile hemangiomasthat was successfully treated with sirolimus and propranolol after failure of combined propranolol and prednisolone treatment.

